Director, HEORBioMarin Pharmaceutical Inc.Lisbon, Lisboa, Portugal
PB0633 - Understanding the Requirement for Additional Factor VIII Infusion Associated with Novel Haemophilia A Treatments: An Expert Elicitation Exercise
Monday, June 26, 202318:30 – 19:30 ET